Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
Friday, June 14, 2024Lisata Therapeutics Inc a clinicalstage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases announced today the successful completion of patient
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202
Friday, June 14, 2024VYNE Therapeutics Inc a clinicalstage biopharmaceutical company developing proprietary innovative and differentiated therapies for the treatment of immunoinflammatory conditions today announced that the first healthy
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
Thursday, June 13, 2024Quoin Pharmaceuticals Ltd a specialty pharmaceutical company focused on rare and orphan diseases today announced that it has signed a research agreement with The School of Pharmacy at University College Cork Ireland
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
Thursday, June 13, 2024Dianthus Therapeutics Inc a clinicalstage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
Wednesday, June 12, 2024Tevogen Bio Holdings Inc a clinicalstage specialty immunotherapy biotech pioneer developing offtheshelf genetically unmodified T cell therapeutics in oncology neurology and virology following the recent elimination
Monopar and NorthStar Amend & Extend Collaboration
Wednesday, June 12, 2024Monopar Therapeutics Inc a clinicalstage radiopharma company and NorthStar Medical Radioisotopes LLC a global innovator in development and commercial production of medical radioisotopes today announced an amendment and expansion to their existing
Alvotech and STADA Add to Strategic Alliance Through Denosumab Partnership
Wednesday, June 12, 2024Alvotech and STADA are strengthening their existing strategic alliance for highquality costeffective biosimilars by extending their partnership to cover AVT a clinicalstage biosimilar candidate referencing
Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster
Tuesday, June 11, 2024Entos Pharmaceuticals a clinicalstage biotechnology company developing genetic medicines with its proprietary Fusogenix PLV nucleic acid delivery platform and its partner Aegis Life Inc
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Saturday, June 08, 2024Moderna Inc today announced that it has submitted an application to the US Food and Drug Administration for review of its Spikevax formula targeting the SARSCoV variant JN For four years Moderna has consistently delivered vaccines
Johnson & Johnson Submits Application to the European Medicines Agency for Approval of the Subcutaneous Formulation of RYBREVANT®▼ (Amivantamab) for the Treatment of Patients
Friday, June 07, 2024JanssenCilag International NV a Johnson Johnson company today announced
